论文部分内容阅读
目的 :评价坦索罗辛 (哈乐 )预防妇科手术后尿潴留的临床价值。方法 :研究组于拔导尿管前 3d开始用哈乐 0 .2mg ,qn ,3～ 5d ;对照组为回顾既往病例 ,拔导尿管前无特殊处理 ,拔导尿管后用传统的方法。比较两组的尿潴留发生率、剩余尿量、感染情况、住院天数等。结果 :研究组的尿潴留发生率为 15 .3% ,对照组为 90 .0 % ;研究组住院天数平均 (10 .8± 3.3)d ,而对照组为 (17.0± 5 .6 )d ,差异内有显著性意义 (P 0 .0 5 )。结论 :哈乐可明显地减少尿潴留的发生率、缩短住院天数 ,是预防和治疗妇科手术后的尿潴留的有效的药物。
Objective: To evaluate the clinical value of tamsulosin in preventing postoperative urinary retention after gynecological surgery. Methods: The study group began to use Halo 0.2 mg qd for 3 to 5 days before pulling the catheter. In the control group, there was no special treatment before pulling the catheter. After pulling the catheter, the traditional method . The incidence of urinary retention, residual urine volume, infection and hospitalization days were compared between the two groups. Results: The incidence of urinary retention was 15.3% in the study group and 90.0% in the control group. The average length of hospital stay in the study group was (10.8 ± 3.3) days compared with (17.0 ± 5.4) days in the control group, The difference was significant (P 0 .0 5). Conclusion: Harmony can significantly reduce the incidence of urinary retention and shorten the length of stay, is to prevent and treat postoperative gynecological urinary retention effective drugs.